Institute BCN
PHOSPHATIDYLCHOLINE
Description
Phosphatidylcholine 5 – Lipolytic Solution
Phosphatidylcholine participates in intracellular and intercellular metabolic transport. Following local administration, fat accumulated within adipocytes is broken down into a nano-emulsion; this emulsion is then transported to the liver, where it is metabolized.
• Emulsification of fat
• Absorption and transport of the emulsion
• Breakdown of fat accumulated in adipocytes (lipolysis)
Manufacturer’s Note: Lipolysis is not an alternative to plastic surgery; it is a therapeutic approach for reducing small volumes of localized fat deposits.
Target areas: Abdomen, flanks, inner and outer thighs, submental area (double chin), and arms.
Patient profile: Patients of average weight with a stable body weight. This product is not intended for the treatment of obesity.
Anatomical restrictions:
• Periorbital area — injection is prohibited.
• A 1–1.5 cm zone extending from the lower border of the jaw must be left untreated. Injection into this area is prohibited.
Contraindications and Precautions
• Injection technique and dosage must strictly follow the manufacturer’s instructions (contains sodium deoxycholate).
• Pregnancy and lactation.
• Inflamed, infected, or damaged skin in the treatment area.
• Individual hypersensitivity or allergy to any of the components.
• Adherence to aseptic and antiseptic standards is mandatory.
• Written informed consent from the patient is required prior to the procedure.
Similar Products